Zimmer Biomet Holdings Inc (ZBH)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$86.00

Buy

$90.89

arrow-down$-0.14 (-0.15%)

Prices updated at 03 Apr 2026, 00:48 EDT

Prices minimum 15 mins delay

Prices in USD

Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris.

S&P 500

0.11%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Ivan Tornos

CEO

Mr. Ivan Tornos

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

17,000

Head office

345 East Main Street

Warsaw

United States

46580

+1 574 373-3333

Zach.Weiner@ZimmerBiomet.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Arthur J. Higgins Independent Director	0.11m
Ms. Betsy J. Bernard Independent Director	0.13m
Mr. Robert A. Hagemann Independent Director	0.14m
Mr. Chad F. Phipps Senior Vice President, General Counsel and Secretary	-
Ms. Maria Teresa Hilado Independent Director	0.11m
Mr. Michael J. Farrell Lead Independent Director	0.13m
Mr. Suketu Upadhyay Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain	0.88m
Mr. Sang Yi Group President, Asia Pacific	0.69m
Ms. Sreelakshmi Kolli Independent Director	0.13m
Mr. Paul Stellato Vice President, Controller and Chief Accounting Officer	-
Mr. Syed A. Jafry Independent Director	0.11m
Mr. Ivan Tornos Chairman of the Board, Director, President and Chief Executive Officer	1.24m
Mr. Kevin R. Thornal Group President, Global Businesses and the Americas	-
Ms. Lori Winkler Senior Vice President and Chief Human Resources Officer	-
Mr. Wilfred van Zuilen Group President, Europe, Middle East and Africa	0.67m
Mr. Devdatt Kurdikar, PhD Independent Director	0.08m
Mr. Louis A. Shapiro Independent Director	0.11m
Mr. Jehanzeb Noor Senior Vice President, Chief Strategy, Business Development, Innovation and Transformation Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Dodge & Cox	23,506,849
Vanguard Group Inc	23,483,741
BlackRock Inc	16,149,859
Dodge & Cox Stock Fund	15,549,900
T. Rowe Price Associates, Inc.	15,082,438

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2025	-
31 Dec 2025	-
31 Dec 2025	-
31 Dec 2025	-
31 Dec 2025	-
31 Dec 2025	-
31 Dec 2025	-
28 Nov 2025	-
28 Nov 2025	-
28 Nov 2025	-
28 Nov 2025	-
28 Nov 2025	-
28 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
10 Nov 2025	-
24 Oct 2025	-
30 Sep 2025	-
30 Sep 2025	-
30 Sep 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.